Piramal Pharma Solutions
Quick Facts: Piramal Pharma Solutions
- Signal Score
- 87.0/100 (as of 2026-11-12)
- Quality Compliance
- 96.1/100 — Clean MHRA record: 14 compliant GMP certificates (no deductions)
- Headquarters
- Lexington, KY · Riverview, MI · Ahmedabad, IN
- Modalities
- Biologics, ADC, Small Molecule API, High-Potency APIs, Oral Solid Dose
- Active Programs
- No ClinicalTrials.gov matches confirmed — 2 partnership signals in press (announcements, not verified)
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Piramal Pharma Solutions
Indian pharma CDMO with US manufacturing.
Signal Score & Pillar Breakdown
Piramal Pharma Solutions FDA Inspection History
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2026-02-13 |
Piramal Pharma Limited
Kohir Mandal
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2025-12-10 |
Piramal Pharma Solutions Inc.
Lexington, Kentucky
Facility-linked
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2025-05-30 |
Piramal Healthcare (Canada) Ltd.
Aurora
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2025-02-17 |
Piramal Pharma Limited
Navi Mumbai
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2023-05-19 |
Piramal Pharma Limited
Pithampur
Company-level
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2023-03-31 |
Piramal Pharma Limited
Kohir Mandal, Sangareddy District
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2023-01-10 |
Piramal Pharma Solutions Inc.
Lexington, Kentucky
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Piramal Pharma Solutions FDA 483 Findings 4 observations · 2025-12-10 → 2025-12-10 ?
By subsystem
By severity
- 5 — Critical: 1
- 3 — Moderate: 1
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Computer control of master formula records
"Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."
-
Investigations of discrepancies, failures
"There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed."
-
Absence of Written Procedures
"Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess."
Piramal Pharma Solutions EMA GMP Compliance 1 certificates
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| NL/H 25/2059654 | Piramal Pharma Solutions (Dutch) B.V. | Netherlands | 2025-11-27 | COMPLIANT |
Piramal Pharma Solutions MHRA GMP Compliance 14 certificates
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK API 29595 Insp GMP/IMP 29595/10933-0018 [H] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK API 29595 Insp GMP/IMP 29595/10933-0018 [V] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK MIA 29595 Insp GMP/IMP 29595/10933-0018[H] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK MIA(IMP) 29595 Insp GMP/IMP 29595/10933-0018[I] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8XG | 2025-09-02 | COMPLIANT |
| UK GMP 18772 Insp GMP 18772/301330-0010 [H] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2025-02-05 | COMPLIANT |
| UK GMP 18772 Insp GMP 18772/301330-0010 [V] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2025-02-05 | COMPLIANT |
| UK API 29595 Insp GMP/GDP/IMP 29595/18244-0044 | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK MIA(IMP) 29595 Insp GMP/GDP/IMP 29595/18244-0044[I] | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK MIA 29595 Insp GMP/GDP/IMP 29595/18244-0044[H] | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK API 29595 Insp GMP 29595/18244-0047 [H] | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK API 29595 Insp GMP 29595/18244-0047 [V] | PIRAMAL HEALTHCARE UK LIMITED | MORPETH NE61 3YA | 2024-12-23 | COMPLIANT |
| UK MIA 29595 Insp GMP 29595/36189300-0002[H] | PIRAMAL HEALTHCARE UK LIMITED | GRANGEMOUTH FK3 8ZF | 2024-02-06 | COMPLIANT |
| UK GMP 54023 Insp GMP 54023/301330-0009 [H] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2019-05-13 | COMPLIANT |
| UK GMP 54023 Insp GMP 54023/301330-0009 [V] | PIRAMAL PHARMA LIMITED | IN-502 321 | 2019-05-13 | COMPLIANT |
Japan-accredited overseas site (PMDA)
sterile, biologics, general (non-sterile) · 6 sites
- Aurora, Canada · Piramal Healthcare (Canada) Limited — general (non-sterile) · valid to Sep 9, 2027
- Navi Mumbai, India · Piramal Pharma Limited — general (non-sterile) · valid to Jul 17, 2029
- Sangareddy, India · Piramal Pharma Limited — general (non-sterile) · valid to Jul 5, 2027
- Grangemouth, United Kingdom · Piramal Healthcare UK Limited — biologics · valid to May 21, 2028
- Morpeth, United Kingdom · Piramal Healthcare UK Limited — general (non-sterile) · valid to Dec 18, 2026 renewal due
- Lexington, United States · Piramal Pharma Solutions Inc. — sterile · valid to Nov 10, 2029
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)